Showing results (2051-2060 of 2,271) with videos related to

Sort By:
Pageof 228
Oral Oncology|April 14, 2015
Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysisLindsay J Joseph, Michael Goodman, Kristin Higgins, et al.
Cancer Research|July 19, 2002
Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanomaJaren W Landen, Roland Lang, Steve J McMahon, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the ratK J Stanhope, N R Mirza, M J Bickerdike, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2013
Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trialR C Smallridge, J A Copland, M S Brose, et al.
Trials|June 20, 2013
Auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ): study protocol for a randomized controlled trialDavid J Berlowitz, Najib Ayas, Maree Barnes, et al.
AJNR. American Journal of Neuroradiology|January 7, 2017
CT Accuracy of Extrinsic Tongue Muscle Invasion in Oral Cavity CancerJ C Junn, K L Baugnon, E A Lacayo, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cellsSuzan Imren, Emmanuel Payen, Karen A Westerman, et al.
Brain : a Journal of Neurology|May 28, 2011
Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factorsDiego N Kaski, Catherine Pennington, Jon Beck, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2020
Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)Corinne Faivre-Finn, David R Spigel, Suresh Senan, et al.
Molecular Psychiatry|March 6, 2021
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseasesAndrew G B Thompson, Prodromos Anastasiadis, Ronald Druyeh, et al.
Pageof 228